Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (ChiCTR2600129047) titled 'Real-World Comparison: Brivudine vs. Valaciclovir for Herpes Zoster' on July 29.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: Dalian Dermatology Hospital
Condition:
Herpes zoster
Intervention:
Brivudine Group:None
Recruitment Status: Not Recruiting
Phase: 4
Date of First Enrollment: 2026-07-30
Target Sample Size: Brivudine Group:400;Valaciclovir Group:400;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=321988
Published by HT Digital Content Services with permission from Health Daily Digest....